Delivery Order SPE2DB25D3306-SPE2DB25FUCXA
Award Date 9/5/25
Potential Completion Date 9/26/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for PROQUAD vials, with a firm fixed price structure and ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded contract representing a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is classified as a child contract, indicating it derives from a larger prime...
- The Defense Logistics Agency awarded a delivery order valued at $3,341.80 to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of September 17, 2025. This is a firm fixed price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,118.64 to AmerisourceBergen Drug Corp for the supply of ProQuad vials. The contract, issued on August 12, 2025, with a completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee and will perform the work at its corporate office location. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,543.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 12, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a $5,372.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of October 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. PROQUAD is a combination...
- The Defense Logistics Agency (DLA) awarded a $1,687.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 19, 2025, with a completion date of September 10, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $8,437.40 to AmerisourceBergen Drug Corp for PROQUAD vials, with a completion date of August 4, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, and performance will occur at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract vehicle. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of AmerisourceBergen Corporation, to provide PROQUAD VIALS. The $3,203.98 contract has a completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations associated with this award. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...
- The Defense Logistics Agency awarded a delivery order valued at $3,374.96 to AmerisourceBergen Drug Corp on May 12, 2025, for PROQUAD vials, with a completion date of June 3, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems, with...
- The Defense Logistics Agency awarded a delivery order valued at $5,480.80 to AmerisourceBergen Drug Corp for PROQUAD vials, a vaccine product, with a completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order was placed with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...